Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease

Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is a widely available curative option for patients with sickle cell disease (SCD). Our original non-myeloablative haplo-HSCT trial employing post-transplant (PT) cyclophosphamide had a low incidence of GVHD but had high rejection ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhat, Deepali K., Olkhanud, Purevdorj B., Gangaplara, Arunakumar, Seifuddin, Fayaz, Pirooznia, Mehdi, Biancotto, Angélique, Fantoni, Giovanna, Pittman, Corinne, Francis, Berline, Dagur, Pradeep K., Saxena, Ankit, McCoy, J. Philip, Pfeiffer, Ruth M., Fitzhugh, Courtney D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669726/
https://www.ncbi.nlm.nih.gov/pubmed/34917079
http://dx.doi.org/10.3389/fimmu.2021.757279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669726/
https://www.ncbi.nlm.nih.gov/pubmed/34917079
http://dx.doi.org/10.3389/fimmu.2021.757279

Ejemplares similares